InvestorsHub Logo
Followers 0
Posts 1326
Boards Moderated 0
Alias Born 01/25/2016

Re: Learjetter post# 44782

Sunday, 11/10/2019 12:26:13 PM

Sunday, November 10, 2019 12:26:13 PM

Post# of 113758
For the articles detailing the scam sale.

Sunshine Biopharma said it has acquired for about $12.8 million all ex-U.S. patents related to its lead anticancer compound from Advanomics.

The company acquired U.S. patent 8,236,935 for Adva-27a in October for a total $4.32 million—12 consecutive annual payments of $360,000—from Advanomics, which at the time owned approximately 23% of Sunshine's issued and outstanding common stock. Sunshine had licensed the U.S. patent from Advanomics for an annual fee of $360,000, plus reimbursement of Advanomics’ R&D expenses, under an agreement that was ended once the U.S. patent changed hands.

In the latest transaction, disclosed yesterday, Sunshine agreed to pay $12,822,499 for remaining rights, title and interest in and to all worldwide patents for Adva-27a (Patent Numbers PCT/FR2007/000697 and PCT/CA2014/000029).

Scam, scam, scam!!!

All imo.
https://www.genengnews.com/topics/translational-medicine/sunshine-biopharma-buys-global-patents-to-lead-cancer-compound/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SBFM News